Click here to sign in with or
by Li Yuan, Chinese Academy of Sciences
The use of antibiotics helps fight bacterial infection, but the abuse of antibiotics has resulted in the emergence and widespread prevalence of "super bacteria," making the treatment of infectious diseases a worldwide problem again.
Photothermal technology (PTT) has received widespread attention for the treatment of bacterial infections. Recently, researchers from Suzhou Institute of Biomedical Engineering and Technology (SIBET) of the Chinese Academy of Sciences have developed bacteria-affinitive photothermal carbon dots (BAPTCDs) from o-phenylenediamine and D-glutamic acid (D-Glu) by a solvothermal method.
BAPTCDs can specifically bind bacteria and rapidly heat up with laser irradiation to destroy bacterial cell walls and kill bacteria.
The study was published in Frontiers in Bioengineering and Biotechnology.
"PTT uses targeted recognition to accumulate photothermal materials near the target tissue and convert light energy into thermal energy via an external light source, usually near-infrared light, to kill bacteria," said Song Yizhi, co-corresponding author of the study.
However, for the specific identification and killing of bacteria, it is very important to develop a specific photothermal bactericidal material.
As an important enzyme in bacterial cell wall synthesis, MurD ligase catalyzes the intermediate with D-Glu. It only exists in prokaryotes, and only prokaryotes can utilize D-type amino acids. Thus, D-Glu derivatives are often used to develop antibacterial agents to kill bacteria by inhibiting cell wall synthesis.
"BAPTCDs have an excellent photothermal effect. The temperature of the BAPTCD solution with different concentrations can increase and stabilize within 10 minutes," said Dr. Qie Xingwang, first author of the study. The maximum temperature of BAPTCDs increased with the increase of material concentration and laser power.
Results of the experiments showed that 80.33% of E. coli and 89.27% of S. aureus were killed by BAPTCDs without NIR, which may contribute to its inhibition of the MurD protein. When irradiated with NIR, only 3.67% of E. coli survived and all of the S. aureus were killed due to the rapidly rising temperature.
"Combined with the advantages of high stability, high fluorescence quantum efficiency, good water solubility and non-toxicity of the carbon dots itself, the BAPTCDs has a very good application prospect," said Dong Wenfei, co-corresponding author of the study. Explore further NIR-II-responsive nickel-based therapy provides new solution for synergistic oncotherapy More information: Xingwang Qie et al, Design, Synthesis, and Application of Carbon Dots With Synergistic Antibacterial Activity, Frontiers in Bioengineering and Biotechnology (2022). DOI: 10.3389/fbioe.2022.894100 Provided by Chinese Academy of Sciences Citation: Scientists develop synergistic antibacterial carbon dots (2022, June 20) retrieved 24 June 2022 from https://phys.org/news/2022-06-scientists-synergistic-antibacterial-carbon-dots.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
More from Physics Forums | Science Articles, Homework Help, Discussion
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Phys.org in any form.
Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we'll never share your details to third parties.
Medical research advances and health news
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use.